Heska Corporation DPO Ratio 2011-2025 | HSKA

Annual DPO Ratio Heska Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
39.7	37.6	34.2	35.3	38.5	48.7	34.3	46.1	33	34	46.4	35.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
48.7	33	38.6

Quarterly DPO Ratio Heska Corporation

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
37.4	-	35.3	29.8	35.5	-	34.7	35.8	39.2	-	41.5	49.5	57.6	-	34.3	38.3	37.8	-	42.2	41.1	39.8	-	51.6	46.9	44.2	-	33.1	37.8	42.9	-	42.3	51.1	44.6	-	33.1	32.3	34.1	-	39.8	30.6	39.8	-	47.5	47.3	41.4	-	33.9	36.6	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
57.6	29.8	40

DPO Ratio of other stocks in the Diagnostics research industry

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	120	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	21.3	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	125	$ 15.82	0.44 %	$ 170 M	China
Accelerate Diagnostics AXDX	125	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	56.3	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	104	$ 1.55	-4.63 %	$ 1.97 M	USA
Oxford Immunotec Global PLC OXFD	45.8	-	-	$ 562 M	Britain
DarioHealth Corp. DRIO	43.9	$ 12.14	2.1 %	$ 344 M	Israel
DexCom DXCM	70.4	$ 65.83	-1.69 %	$ 25.4 B	USA
Castle Biosciences CSTL	52	$ 39.06	1.11 %	$ 1.08 B	USA
Chembio Diagnostics CEMI	52.5	-	0.22 %	$ 16.8 M	USA
Exact Sciences Corporation EXAS	139	$ 101.64	0.14 %	$ 18.8 B	USA
Danaher Corporation DHR	66.4	$ 227.72	0.54 %	$ 166 B	USA
Fulgent Genetics FLGT	34.9	$ 27.0	-0.52 %	$ 816 M	USA
Global Cord Blood Corporation CO	17.7	-	-	$ 399 M	China
Fluidigm Corporation FLDM	61.4	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	780	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	43.5	-	0.12 %	$ 80.1 M	China
DermTech DMTK	47.4	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	8.98	-	-	$ 10.7 B	USA
CareDx, Inc CDNA	44.2	$ 19.98	-2.82 %	$ 1.07 B	USA
Enzo Biochem ENZ	52.3	-	-8.98 %	$ 14.8 K	USA
Anixa Biosciences ANIX	1.29 K	$ 3.3	-7.82 %	$ 105 K	USA
Co-Diagnostics CODX	106	$ 0.29	-14.47 %	$ 8.51 M	USA
IQVIA Holdings IQV	126	$ 222.75	0.24 %	$ 40.4 B	USA
Guardant Health GH	83.6	$ 103.7	1.6 %	$ 12.7 B	USA
Aspira Women's Health AWH	112	-	-6.19 %	$ 10.5 M	USA
HTG Molecular Diagnostics HTGM	112	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	56.3	$ 134.4	-0.35 %	$ 21.4 B	USA
Charles River Laboratories International CRL	24.5	$ 197.62	2.4 %	$ 10.2 B	USA
Quotient Limited QTNT	86.2	-	-11.32 %	$ 1.1 M	Schweiz
Mettler-Toledo International MTD	53.4	$ 1 410.02	1.15 %	$ 29.9 B	Schweiz
Quest Diagnostics Incorporated DGX	18.3	$ 183.96	0.79 %	$ 20.4 B	USA
NeoGenomics NEO	20.7	$ 12.03	1.48 %	$ 1.52 B	USA
Neogen Corporation NEOG	62.7	$ 6.85	-0.22 %	$ 1.49 B	USA
Myriad Genetics MYGN	42	$ 7.04	-2.36 %	$ 638 M	USA
Laboratory Corporation of America Holdings LH	33.1	$ 262.89	-0.48 %	$ 22.1 B	USA
ICON Public Limited Company ICLR	6.52	$ 184.38	-1.18 %	$ 15.2 B	Irlanda
IDEXX Laboratories IDXX	27	$ 698.77	-0.77 %	$ 57.6 B	USA
Lantheus Holdings LNTH	25.3	$ 66.4	-0.33 %	$ 4.59 B	USA
Agilent Technologies A	50.1	$ 140.3	0.46 %	$ 42.7 B	USA
Biomerica BMRA	32.4	$ 2.48	-2.65 %	$ 5.7 M	USA
Bioventus BVS	59.2	$ 7.49	-0.86 %	$ 469 M	USA
Pacific Biosciences of California PACB	33.5	$ 2.13	0.24 %	$ 540 M	USA
Motus GI Holdings MOTS	1.72	-	-34.28 %	$ 263 K	Israel